Status:
TERMINATED
Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of AZD1386 in Patients With Osteoarthritis (OA) of the Knee
Lead Sponsor:
AstraZeneca
Conditions:
Pain
Eligibility:
All Genders
40-80 years
Phase:
PHASE2
Brief Summary
The primary aim of this study is to investigate if AZD1386 is efficacious as an analgesic in patients with osteoarthritis of the knee and at what dose. This will be done by comparing the effect of AZD...
Eligibility Criteria
Inclusion
- Patients with OA of the knee
- Male or non pregnant females 40 and 80 years old
Exclusion
- A current diagnosis of another form of arthritis, in addition to OA
- History, and/or presence of somatic disease, which may interfere with the objectives
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
241 Patients enrolled
Trial Details
Trial ID
NCT00878501
Start Date
March 1 2009
End Date
July 1 2009
Last Update
June 4 2012
Active Locations (41)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Pleven, Bulgaria
2
Research Site
Sofia, Bulgaria
3
Research Site
Bay Roberts, Newfoundland and Labrador, Canada
4
Research Site
St. John's, Newfoundland and Labrador, Canada